Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients
Background. Suppressor of tumorigenicity 2 (ST2) is a key biomarker in inflammation and cardiovascular diseases, but limited data is available on its role in allergic rhinitis (AR). Objective. The aim of this study is to explore the role of serum soluble ST2 (sST2) in evaluating disease severity and...
Saved in:
Main Authors: | Kang Zhu, Cui Xia, Jingguo Chen, Chao Yu, Tianxi Gao, Jing Yan, Na Shao, Pin Zhu, Bin Sun, Xiaoyong Ren, Yanni Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2021/5576596 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
by: Yandan Zhou, et al.
Published: (2022-01-01) -
Evaluation of Clinical and Immunological Responses: A 2-Year Follow-Up Study in Children with Allergic Rhinitis due to House Dust Mite
by: Heleen Moed, et al.
Published: (2013-01-01) -
CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01) -
A study of specific immunoglobulin G4 expression in allergic rhinitis and its value in assessing efficacy and in predicting prognosis of sublingual immunotherapy
by: Ting‐Ting Wei, et al.
Published: (2025-01-01) -
House dust mite allergy – Management
by: P. C. Kathuria, et al.
Published: (2024-12-01)